• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检查点抑制剂相关心肌炎及类固醇反应的神经网络建模

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response.

作者信息

Stefanovic Filip, Gomez-Caminero Andres, Jacobs David M, Subramanian Poornima, Puzanov Igor, Chilbert Maya R, Feuerstein Steven G, Yatsynovich Yan, Switzer Benjamin, Schentag Jerome J

机构信息

Department of Biomedical Engineering, University at Buffalo School of Engineering and Applied Sciences, Buffalo, NY, USA.

CPL Associates LLC, Buffalo, NY, USA.

出版信息

Clin Pharmacol. 2022 Aug 10;14:69-90. doi: 10.2147/CPAA.S369008. eCollection 2022.

DOI:10.2147/CPAA.S369008
PMID:35975122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9376002/
Abstract

BACKGROUND

Serious but rare side effects associated with immunotherapy pose a difficult problem for regulators and practitioners. Immune checkpoint inhibitors (ICIs) have come into widespread use in oncology in recent years and are associated with rare cardiotoxicity, including potentially fatal myocarditis. To date, no comprehensive model of myocarditis progression and outcomes integrating time-series based laboratory and clinical signals has been constructed. In this paper, we describe a time-series neural net (NN) model of ICI-related myocarditis derived using supervised machine learning.

METHODS

We extracted and modeled data from electronic medical records of ICI-treated patients who had an elevation in their troponin. All data collection was performed using an electronic case report form, with approximately 300 variables collected on as many occasions as available, yielding 6000 data elements per patient over their clinical course. Key variables were scored 0-5 and sequential assessments were used to construct the model. The NN model was developed in MatLab and applied to analyze the time course and outcomes of treatments.

RESULTS

We identified 23 patients who had troponin elevations related to their ICI therapy, 15 of whom had ICI-related myocarditis, while the remaining 8 patients on ICIs had other causes for troponin elevation, such as myocardial infarction. Our model showed that troponin was the most predictive biomarker of myocarditis, in line with prior studies. Our model also identified early and aggressive use of steroid treatment as a major determinant of survival for cases of grade 3 or 4 ICI-related myocarditis.

CONCLUSION

Our study shows that a supervised learning NN can be used to model rare events such as ICI-related myocarditis and thus provide clinical insight into drivers of progression and treatment outcomes. These findings direct attention to early detection biomarkers and clinical symptoms as the best means of implementing early and potentially life-saving steroid treatment.

摘要

背景

免疫疗法相关的严重但罕见的副作用给监管机构和从业者带来了难题。免疫检查点抑制剂(ICI)近年来在肿瘤学中已广泛应用,且与罕见的心脏毒性有关,包括潜在致命的心肌炎。迄今为止,尚未构建出一个整合基于时间序列的实验室和临床信号的心肌炎进展及预后综合模型。在本文中,我们描述了一种使用监督式机器学习得出的ICI相关心肌炎的时间序列神经网络(NN)模型。

方法

我们从接受ICI治疗且肌钙蛋白升高的患者的电子病历中提取数据并进行建模。所有数据收集均使用电子病例报告表,尽可能多地收集约300个变量,每位患者在其临床过程中产生6000个数据元素。关键变量评分为0至5分,并使用连续评估来构建模型。NN模型在MatLab中开发,并应用于分析治疗的时间进程和结果。

结果

我们确定了23例肌钙蛋白升高与ICI治疗相关的患者,其中15例患有ICI相关心肌炎,而其余8例接受ICI治疗的患者肌钙蛋白升高有其他原因,如心肌梗死。我们的模型表明,肌钙蛋白是心肌炎最具预测性的生物标志物,这与先前的研究一致。我们的模型还确定,早期积极使用类固醇治疗是3级或4级ICI相关心肌炎病例生存的主要决定因素。

结论

我们的研究表明,监督学习的NN可用于对ICI相关心肌炎等罕见事件进行建模,从而为进展驱动因素和治疗结果提供临床见解。这些发现将注意力引向早期检测生物标志物和临床症状,将其作为实施早期且可能挽救生命的类固醇治疗的最佳手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/478819d90b0c/CPAA-14-69-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/a308d09de055/CPAA-14-69-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/a7a4dd5b84a1/CPAA-14-69-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/d17876082616/CPAA-14-69-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/478819d90b0c/CPAA-14-69-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/a308d09de055/CPAA-14-69-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/a7a4dd5b84a1/CPAA-14-69-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/d17876082616/CPAA-14-69-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/9376002/478819d90b0c/CPAA-14-69-g0004.jpg

相似文献

1
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response.检查点抑制剂相关心肌炎及类固醇反应的神经网络建模
Clin Pharmacol. 2022 Aug 10;14:69-90. doi: 10.2147/CPAA.S369008. eCollection 2022.
2
Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.与心肌炎重叠的免疫检查点抑制剂相关肌炎:一项机构病例系列研究及文献系统综述
Front Pharmacol. 2022 May 12;13:884776. doi: 10.3389/fphar.2022.884776. eCollection 2022.
3
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎患者的临床特征、病程、治疗和结局。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002553.
4
Prognosis of immune checkpoint inhibitor-related myocarditis: Retrospective experience of a single institution.免疫检查点抑制剂相关心肌炎的预后:单中心回顾性经验。
Int Immunopharmacol. 2024 Jul 30;136:112385. doi: 10.1016/j.intimp.2024.112385. Epub 2024 Jun 7.
5
Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.Ga-DOTATOC PET/CT 检测免疫检查点抑制剂相关心肌炎。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003594.
6
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗患者的心肌炎。
J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19.
7
Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors.免疫检查点抑制剂治疗的癌症患者心肌炎的前瞻性筛查。
J Cardiol. 2023 Jan;81(1):63-67. doi: 10.1016/j.jjcc.2022.07.009. Epub 2022 Aug 9.
8
A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil.一例使用阿巴西普和霉酚酸酯治疗免疫检查点抑制剂相关类固醇难治性心肌炎和重症肌无力样肌炎的病例报告。
Eur Heart J Case Rep. 2021 Aug 18;5(11):ytab342. doi: 10.1093/ehjcr/ytab342. eCollection 2021 Nov.
9
PD-1 inhibitors-associated myocarditis in non-small cell lung cancer patients.非小细胞肺癌患者中与程序性死亡受体1(PD-1)抑制剂相关的心肌炎
J Thorac Dis. 2023 Sep 28;15(9):4606-4619. doi: 10.21037/jtd-23-596. Epub 2023 Aug 14.
10
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.生物标志物在免疫检查点抑制剂相关心肌炎管理中的作用。
Curr Cardiol Rep. 2023 Sep;25(9):959-967. doi: 10.1007/s11886-023-01915-5. Epub 2023 Jul 12.

引用本文的文献

1
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers.免疫检查点抑制剂相关性心肌炎综述:流行病学、发病机制及生物标志物
Hum Vaccin Immunother. 2025 Dec;21(1):2512645. doi: 10.1080/21645515.2025.2512645. Epub 2025 Jun 12.
2
Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review.人工智能在心脏肿瘤学中的应用:综述
Curr Cardiol Rep. 2025 Feb 19;27(1):56. doi: 10.1007/s11886-025-02215-w.
3
Artificial intelligence and myocarditis-a systematic review of current applications.

本文引用的文献

1
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.神经免疫相关免疫检查点抑制剂不良事件的共识疾病定义。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002890.
2
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎患者的临床特征、病程、治疗和结局。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002553.
3
A multicenter characterization of hepatitis associated with immune checkpoint inhibitors.
人工智能与心肌炎——当前应用的系统综述。
Heart Fail Rev. 2024 Nov;29(6):1217-1234. doi: 10.1007/s10741-024-10431-9. Epub 2024 Aug 14.
4
Development and validation of a prediction tool for intraoperative blood transfusion in brain tumor resection surgery: a retrospective analysis.开发和验证用于脑肿瘤切除术术中输血预测的工具:回顾性分析。
Sci Rep. 2023 Oct 13;13(1):17428. doi: 10.1038/s41598-023-44549-x.
免疫检查点抑制剂相关肝炎的多中心特征分析
Oncoimmunology. 2021 Feb 8;10(1):1875639. doi: 10.1080/2162402X.2021.1875639.
4
Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report.在一名恶性胸膜间皮瘤患者中,尽管心肌炎和肌炎临床缓解,但纳武单抗导致肌钙蛋白水平持续升高:病例报告
Transl Lung Cancer Res. 2020 Apr;9(2):360-365. doi: 10.21037/tlcr.2020.02.05.
5
Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report.帕博利珠单抗引发转移性膀胱癌患者同时出现重症肌无力和心肌炎:一例病例报告
Urol Case Rep. 2020 Feb 26;31:101145. doi: 10.1016/j.eucr.2020.101145. eCollection 2020 Jul.
6
Unanticipated Myocarditis in a Surgical Patient Treated With Pembrolizumab: A Case Report.帕博利珠单抗治疗的外科手术患者中出现的意外性心肌炎:一例报告
A A Pract. 2020 Apr;14(6):e01177. doi: 10.1213/XAA.0000000000001177.
7
Case of pembrolizumab-induced myocarditis presenting as torsades de pointes with safe re-challenge.帕博利珠单抗诱发的心肌炎表现为尖端扭转型室速且成功再次激发的病例。
J Oncol Pharm Pract. 2020 Sep;26(6):1544-1548. doi: 10.1177/1078155220904152. Epub 2020 Feb 23.
8
Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment.纳武单抗治疗后出现严重心肌炎并伴有轻微淋巴细胞浸润。
Lung Cancer. 2020 Feb;140:116-117. doi: 10.1016/j.lungcan.2019.12.004. Epub 2019 Dec 9.
9
Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.纳武单抗和伊匹单抗诱发的肌炎和心肌炎,表现类似重症肌无力。
Neuromuscul Disord. 2020 Jan;30(1):67-69. doi: 10.1016/j.nmd.2019.10.006. Epub 2019 Nov 4.
10
Toward a grey box approach for cardiovascular physiome.迈向心血管生理组学的灰箱方法。
Korean J Physiol Pharmacol. 2019 Sep;23(5):305-310. doi: 10.4196/kjpp.2019.23.5.305. Epub 2019 Aug 26.